News

Healthcare Shares Plunge

1 Mins read

The recent FDA advisory committee vote on Medtronic’s Symplicity Spyral device has sent shockwaves through the healthcare industry. While the panel unanimously voted in favor of the device’s safety, opinions were divided on its overall effectiveness and benefit/risk profile. These non-binding recommendations from the FDA often shape the agency’s decisions, although they are not legally binding.

Medtronic remains committed to working closely with the FDA to address concerns and further refine their innovative device. The clinical trial results have been a mix of successes and challenges, which will undoubtedly be taken into consideration moving forward.

In a concerning turn of events, this year’s updated Covid-19 vaccines are facing delays in reaching pharmacies. Despite the surge in Covid-19 cases across the nation, U.S. regulators anticipate the availability of these updated vaccines to be delayed until “mid-to-late September.” This setback raises concerns about effectively managing the ongoing pandemic.

On a more positive note, Questa Capital has successfully raised an impressive $397 million for their largest venture fund. This fund aims to support growth-stage healthcare companies, particularly those focused on connected medical devices and those advocating for value-based care. This significant investment demonstrates the continued interest and confidence in advancing healthcare technologies and systems.

Related posts
News

Cardano Price Prediction: Will ADA Be a Top Performer in 2025?

5 Mins read
Cardano price prediction is on everyone’s mind as investors wonder if ADA will get back to previous highs or even new records….
News

Trump selects a new Tesla on White House driveway to show support for Musk

7 Mins read
President Donald Trump shopped for a new Tesla on the White House driveway on Tuesday, selecting a shiny red sedan to show…
News

Crypto firms may not have to register as trading systems under US SEC's new plan

1 Mins read
The acting chief of the US Securities and Exchange Commission said on Monday he has directed staff to look at ways to…

Leave a Reply

Your email address will not be published. Required fields are marked *